Malaria Vaccines Market

The malaria vaccines market provides preventative treatments for a life-threatening disease caused by the Plasmodium parasite. Key customers include vulnerable populations in endemic areas, such as children under five and pregnant women, as well as travelers. Growth is primarily driven by the rising global incidence of malaria, the ineffectiveness of traditional prevention methods, and significant R&D initiatives from pharmaceutical companies and collaborating organizations.